Addex Therapeutics Total Assets Growth & History (ADXN)
Addex Therapeutics's total assets was CHF6.4M for fiscal 2025.
View full Addex Therapeutics company overviewAddex Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | CHF6.4M | −CHF4.3M | −40.40% |
| 2024 | 2024-12-31 | CHF10.7M | CHF6.0M | +130.04% |
| 2023 | 2023-12-31 | CHF4.6M | −CHF3.6M | −43.95% |
| 2022 | 2022-12-31 | CHF8.3M | −CHF14.3M | −63.26% |
| 2021 | 2021-12-31 | CHF22.5M | CHF2.4M | +11.69% |
| 2020 | 2020-12-31 | CHF20.2M | −CHF12.8M | −38.90% |
| 2019 | 2019-12-31 | CHF33.0M | −CHF9.2M | −21.76% |
| 2018 | 2018-12-31 | CHF42.2M | — | — |
Addex Therapeutics quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | CHF4.8M | −CHF4.7M | −49.82% |
| Q4 2025 | 2025-12-31 | CHF6.4M | −CHF4.3M | −40.40% |
| Q3 2025 | 2025-09-30 | CHF7.3M | — | — |
| Q2 2025 | 2025-06-30 | CHF8.5M | — | — |
| Q1 2025 | 2025-03-31 | CHF9.5M | — | — |
| Q4 2024 | 2024-12-31 | CHF10.7M | CHF6.0M | +130.04% |
| Q4 2023 | 2023-12-31 | CHF4.6M | −CHF3.6M | −43.95% |
| Q2 2023 | 2023-06-30 | CHF9.0M | — | — |
| Q4 2022 | 2022-12-31 | CHF8.3M | −CHF14.3M | −63.26% |
| Q4 2021 | 2021-12-31 | CHF22.5M | CHF2.4M | +11.69% |
| Q4 2020 | 2020-12-31 | CHF20.2M | −CHF12.8M | −38.90% |
| Q4 2019 | 2019-12-31 | CHF33.0M | −CHF9.2M | −21.76% |
| Q4 2018 | 2018-12-31 | CHF42.2M | — | — |
Addex Therapeutics total assets trends
Over the last five fiscal years, Addex Therapeutics's total assets decreased from CHF20.2M to CHF6.4M, a change of −CHF13.8M. The latest reported quarter, Q1 2026, shows CHF4.8M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Addex Therapeutics source filings ↗